Akèy › Nefwòz lipoyid › Texas
Etid klinik pou Nefwòz lipoyid nan Texas
4 etid pou Nefwòz lipoyid ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Prolato Clinical Research Center, Houston
- Clinical Trial Network, Houston
- Clinical Advancement Center, San Antonio
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.